Blood Epidemiology and Clinical Therapeutics

Funding of clinical research in non-malignant blood diseases and cell therapies (e.g., hematopoietic stem cell transplants, transfusion products, and novel cell therapies) including epidemiologic studies, data science, patient-reported outcomes, observational clinical studies; and clinical trials that test therapeutic, behavioral, prevention, and/or implementation strategies.